Class information for:
Level 1: UNIV INTEGRATED HOSP//PROSTATE CANCER//TOTAL TESTOSTERONE TT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
12558 897 37.1 83%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
159 3       MENOPAUSE//ISOFLAVONES//TAMOXIFEN 61134
827 2             MAMMOGRAPHIC DENSITY//BREAST DENSITY//METFORMIN 11860
12558 1                   UNIV INTEGRATED HOSP//PROSTATE CANCER//TOTAL TESTOSTERONE TT 897

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNIV INTEGRATED HOSP address 204241 1% 100% 6
2 PROSTATE CANCER authKW 159948 39% 1% 354
3 TOTAL TESTOSTERONE TT authKW 136161 0% 100% 4
4 FREE TESTOSTERONE FT authKW 121569 1% 71% 5
5 PERIPROSTATIC ADIPOSE TISSUE authKW 121569 1% 71% 5
6 PERIPROSTATIC FAT authKW 102121 0% 100% 3
7 DUKE PROSTATE address 97102 3% 11% 25
8 DUKE PROSTATE CANC address 76589 0% 75% 3
9 PROSTATE SPECIFIC ANTIGEN authKW 74745 10% 2% 89
10 PROSTATIC NEOPLASMS authKW 71390 11% 2% 102

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Urology & Nephrology 21930 45% 0% 408
2 Oncology 5597 41% 0% 370
3 Public, Environmental & Occupational Health 970 14% 0% 130
4 Endocrinology & Metabolism 764 12% 0% 110
5 Andrology 314 1% 0% 11
6 Nutrition & Dietetics 13 2% 0% 15
7 Medicine, General & Internal 8 3% 0% 29
8 Medicine, Research & Experimental 7 2% 0% 21
9 Radiology, Nuclear Medicine & Medical Imaging 2 2% 0% 18
10 Pathology 0 1% 0% 8

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UNIV INTEGRATED HOSP 204241 1% 100% 6
2 DUKE PROSTATE 97102 3% 11% 25
3 DUKE PROSTATE CANC 76589 0% 75% 3
4 INTERNAL MED ENDOCRINOL SECT 61270 0% 60% 3
5 UROL 51800 45% 0% 408
6 BCGI 34040 0% 100% 1
7 BIOL SPECIALISEE ONCONGENET 34040 0% 100% 1
8 BOARD HLTH WELF CANC EPIDEMIOL 34040 0% 100% 1
9 CELLULAR STRUCT BIOL UROL 34040 0% 100% 1
10 CHEM CLIN DIAGNOST 34040 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PROSTATE CANCER AND PROSTATIC DISEASES 30314 3% 3% 31
2 PROSTATE 21017 6% 1% 53
3 CANCER CAUSES & CONTROL 16684 4% 1% 40
4 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 13487 6% 1% 50
5 BJU INTERNATIONAL 9610 5% 1% 48
6 UROLOGY 6747 6% 0% 57
7 ACTAS UROLOGICAS ESPANOLAS 3454 1% 1% 10
8 CLINICAL ONCOLOGY-US 3402 0% 10% 1
9 JOURNAL OF UROLOGY 3252 6% 0% 52
10 UROLOGIA INTERNATIONALIS 2664 2% 0% 19

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 PROSTATE CANCER 159948 39% 1% 354 Search PROSTATE+CANCER Search PROSTATE+CANCER
2 TOTAL TESTOSTERONE TT 136161 0% 100% 4 Search TOTAL+TESTOSTERONE+TT Search TOTAL+TESTOSTERONE+TT
3 FREE TESTOSTERONE FT 121569 1% 71% 5 Search FREE+TESTOSTERONE+FT Search FREE+TESTOSTERONE+FT
4 PERIPROSTATIC ADIPOSE TISSUE 121569 1% 71% 5 Search PERIPROSTATIC+ADIPOSE+TISSUE Search PERIPROSTATIC+ADIPOSE+TISSUE
5 PERIPROSTATIC FAT 102121 0% 100% 3 Search PERIPROSTATIC+FAT Search PERIPROSTATIC+FAT
6 PROSTATE SPECIFIC ANTIGEN 74745 10% 2% 89 Search PROSTATE+SPECIFIC+ANTIGEN Search PROSTATE+SPECIFIC+ANTIGEN
7 PROSTATIC NEOPLASMS 71390 11% 2% 102 Search PROSTATIC+NEOPLASMS Search PROSTATIC+NEOPLASMS
8 RM1 CELLS 68080 0% 100% 2 Search RM1+CELLS Search RM1+CELLS
9 PSA MASS 45386 0% 67% 2 Search PSA+MASS Search PSA+MASS
10 BODY MASS INDEX 37005 12% 1% 111 Search BODY+MASS+INDEX Search BODY+MASS+INDEX

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 CAO, Y , MA, J , (2011) BODY MASS INDEX, PROSTATE CANCER-SPECIFIC MORTALITY, AND BIOCHEMICAL RECURRENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS.CANCER PREVENTION RESEARCH. VOL. 4. ISSUE 4. P. 486 -501 46 75% 126
2 FREEDLAND, SJ , PLATZ, EA , (2007) OBESITY AND PROSTATE CANCER: MAKING SENSE OUT OF APPARENTLY CONFLICTING DATA.EPIDEMIOLOGIC REVIEWS. VOL. 29. ISSUE . P. 88-97 68 59% 102
3 BUSCHEMEYER, WC , FREEDLAND, SJ , (2007) OBESITY AND PROSTATE CANCER: EPIDEMIOLOGY AND CLINICAL IMPLICATIONS.EUROPEAN UROLOGY. VOL. 52. ISSUE 2. P. 331-343 66 55% 123
4 KLAP, J , SCHMID, M , LOUGHLIN, KR , (2015) THE RELATIONSHIP BETWEEN TOTAL TESTOSTERONE LEVELS AND PROSTATE CANCER: A REVIEW OF THE CONTINUING CONTROVERSY.JOURNAL OF UROLOGY. VOL. 193. ISSUE 2. P. 403 -413 36 80% 11
5 HSING, AW , SAKODA, LC , CHUA, SC , (2007) OBESITY, METABOLIC SYNDROME, AND PROSTATE CANCER.AMERICAN JOURNAL OF CLINICAL NUTRITION. VOL. 86. ISSUE 3. P. 843S-857S 46 61% 143
6 ALLOTT, EH , MASKO, EM , FREEDLAND, SJ , (2013) OBESITY AND PROSTATE CANCER: WEIGHING THE EVIDENCE.EUROPEAN UROLOGY. VOL. 63. ISSUE 5. P. 800-809 42 46% 117
7 PIERCE, BL , (2012) WHY ARE DIABETICS AT REDUCED RISK FOR PROSTATE CANCER? A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE.UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. VOL. 30. ISSUE 5. P. 735 -743 47 59% 16
8 HU, MB , XU, H , BAI, PD , JIANG, HW , DING, Q , (2014) OBESITY HAS MULTIFACETED IMPACT ON BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: A DOSE-RESPONSE META-ANALYSIS OF 36,927 PATIENTS.MEDICAL ONCOLOGY. VOL. 31. ISSUE 2. P. - 31 79% 8
9 DIMITROPOULOU, P , MARTIN, RM , TURNER, EL , LANE, JA , GILBERT, R , DAVIS, M , DONOVAN, JL , HAMDY, FC , NEAL, DE , (2011) ASSOCIATION OF OBESITY WITH PROSTATE CANCER: A CASE-CONTROL STUDY WITHIN THE POPULATION-BASED PSA TESTING PHASE OF THE PROTECT STUDY.BRITISH JOURNAL OF CANCER. VOL. 104. ISSUE 5. P. 875 -881 40 68% 9
10 TOMASZEWSKI, JJ , CHEN, YF , BERTOLET, M , RISTAU, BT , WOLDEMICHAEL, E , NELSON, JB , (2013) OBESITY IS NOT ASSOCIATED WITH AGGRESSIVE PATHOLOGIC FEATURES OR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY.UROLOGY. VOL. 81. ISSUE 5. P. 992-996 26 90% 8

Classes with closest relation at Level 1


Rank Class id link
1 11230 PROSTATE CANCER//ALVA 101//HLTH SCI 66 124
2 6777 COLORECTAL ADENOMA//ADVANCED ADENOMATOUS POLYPS//BREAST ONCODIABETOLOGY
3 10768 LEPTIN//ADIPONECTIN//LEPTIN RECEPTOR
4 15439 CAG REPEAT//ANDROGEN RECEPTOR GENE//ANDROGEN RECEPTOR
5 596 HYPOGONADISM//TESTOSTERONE//TESTOSTERONE REPLACEMENT THERAPY
6 12848 JAMAICA CANC REGISTRY//AFRICAN AMERICAN MEN//PROSTATE CANCER SCREENING
7 10287 METFORMIN//ANTIDIABETIC BIGUANIDES//PHENFORMIN
8 1816 ANDROGEN DEPRIVATION THERAPY//BICALUTAMIDE//COMBINED ANDROGEN BLOCKADE
9 1451 ACTIVE SURVEILLANCE//WATCHFUL WAITING//PROSTATE SPECIFIC ANTIGEN
10 976 PROSTATE SPECIFIC ANTIGEN//FREE PSA//PSA

Go to start page